Advanced search
Publication Cover
Journal of Medical Economics Volume 22, 2019 - Issue 9
Submit an article Journal homepage
2,933
Views
3
CrossRef citations to date
0
Altmetric
Oncology

Converting EORTC QLQ-C30 scores to utility scores in the brigatinib ALTA study

Ariane K. KawataEvidera, Inc, Bethesda, MD, USA; Correspondence[email protected]
,
William R. LenderkingEvidera, Inc, Bethesda, MD, USA;
,
Olabimpe R. EseyinEvidera, Inc, Bethesda, MD, USA;
,
David KersteinMillennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
,
Joice HuangMillennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
,
Hui HuangMillennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
,
Pingkuan ZhangMillennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
&
Huamao M. LinMillennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company LimitedORCID Iconhttp://orcid.org/0000-0002-8399-8966
ORCID Icon show all
Pages 924-935 | Received 31 Jan 2019, Accepted 22 May 2019, Published online: 25 Jun 2019

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Erika Rijavec, Federica Biello, Alice Indini, Francesco Grossi & Carlo Genova. (2022) Current Insights on the Treatment of Anaplastic Lymphoma Kinase-Positive Metastatic Non-Small Cell Lung Cancer: Focus on Brigatinib. Clinical Pharmacology: Advances and Applications 14, pages 1-9.
Read now
Luigi Cavanna, Chiara Citterio & Elena Orlandi. (2020) Feasibility and Utility of Incorporating Patient-Reported Outcomes into Surveillance Strategies for Advanced Lung Cancer. Patient Related Outcome Measures 11, pages 49-66.
Read now

Articles from other publishers (1)

Salvador Guardiola, Monica Varese, Macarena Sánchez-Navarro & Ernest Giralt. (2019) A Third Shot at EGFR: New Opportunities in Cancer Therapy. Trends in Pharmacological Sciences 40:12, pages 941-955.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.